DocGo deploys no-cost testing program

LabPulse.com staff writers
Sep 19, 2021
2021 04 27 22 24 2298 Nasal Swab Test 400

Mobile health services provider DocGo has deployed a no-cost, multiplex co-testing program that includes rapid antigen tests for influenza A and B.

In partnership with NYC Test & Trace Corps and NYC Health + Hospitals, DocGo made the new tests available last week across its mobile health fleet and street health and wellness outreach units. The single-swab assays test for multiple viruses at once and provide patients with results in 15 minutes or less.

Latest in Infectious
Sepsis Bacteria Social
Siemens Healthineers contracts with NIAID to develop NGS-based sepsis test
November 22, 2023
Bacteria Blood Sepsis Social
Nanopore Technologies, Day Zero Diagnostics to collaborate on sepsis diagnostic solution
November 20, 2023
Money Hundred Bills Social
Cytovale raises $84M in series C funding
November 16, 2023
Infectious Diseases Research Social
Illumina launches pricing program for pathogen sequencing tools in LMICs
November 13, 2023
Related Stories
2021 08 04 21 10 9313 Senior Elderly Vaccine 400
Influenza
Flu shots may protect against severe COVID-19
2019 05 24 21 56 3410 Gonorrhea Neisseria Gonorrhoeae 400
Chlamydia
USPSTF: Evidence weak for screening men for chlamydia, gonorrhea
2019 05 13 16 12 9218 Lab Blood Woman2 400
Infectious
BizVibe adds to diagnostic lab industry profiles
2021 02 09 23 31 9697 Business Contract Signing 400
Infectious
Serosep secures contract with Liverpool University Hospital
More in Infectious
Siemens Healthineers contracts with NIAID to develop NGS-based sepsis test
Siemens Healthineers has secured a three-year, $5.5 million contract with the National Institute of Allergy and Infectious Diseases (NIAID), a division of the U.S. National Institutes of Health, to develop a test to improve sepsis treatment.
November 22, 2023
Sepsis Bacteria Social
Nanopore Technologies, Day Zero Diagnostics to collaborate on sepsis diagnostic solution
Oxford, U.K.-based Oxford Nanopore Technologies and Boston-based infectious disease diagnostics firm Day Zero Diagnostics have announced a partnership to develop an end-to-end solution for the diagnosis of bloodstream infections.
November 20, 2023
Bacteria Blood Sepsis Social
Cytovale raises $84M in series C funding
Medical technology firm Cytovale has raised $84 million in a series C financing round that the firm says it will use to expand the commercialization of its 10-minute IntelliSep test.
November 16, 2023
Money Hundred Bills Social
Illumina launches pricing program for pathogen sequencing tools in LMICs
Illumina has launched its Global Health Access Initiative program to provide pathogen sequencing tools at lower prices in low- and middle-income countries (LMICs).
November 13, 2023
Infectious Diseases Research Social
AI model could predict viral mutation, aid vaccine design
Researchers have developed a new artificial intelligence (AI) tool which they say could help predict new viral variants before they emerge.
October 31, 2023
Sequencing Virus Social
WHO launches expert review panel for NTD diagnostics
The World Health Organization (WHO) has created a pilot scheme for an expert review panel for diagnostic products as part of its program for neglected tropical diseases (NTDs).
October 13, 2023
Infectious Diseases Research Social
NIH researchers develop PCR assay for easier diagnosis of river blindness
U.S. National Institutes of Health (NIH) researchers have developed a new PCR assay to detect Onchocerca volvulus, the parasite that causes onchocerciasis, or river blindness, and are working to adapt it for easier field diagnosis of the disease.
October 9, 2023
Test Tubes Social
BioMérieux subsidiary secures DoD contract for infectious disease testing system
BioFire Defense, a subsidiary of BioMérieux, has secured an order-dependent contract with the U.S. Department of Defense (DoD) to provide support for a military-use version of its multiplex polymerase chain reaction infectious disease test system.
September 29, 2023
Test Tube Liquid Sample Social
Study shows malaria drug resistance occurring in Horn of Africa
Malaria parasites in eastern Africa have developed resistance to artemisinins, essential first-line drugs used in combination therapies, jeopardizing the progress made in recent decades against the disease.
September 29, 2023
Plasmodium Falciparum Malaria Cdc Social
Day Zero Diagnostics to use $16M in funding to improve management of antibiotic-resistant infections
Day Zero Diagnostics recently raised $16 million to fund the application of whole-genome sequencing and artificial intelligence to antibiotic-resistant infections, facilitating the firm’s goal of changing how infectious diseases are diagnosed.
September 28, 2023
Dna Sequencing2
Some emergency sepsis screening tools inadequate, EU study suggests
Two out of the four internationally recommended screening tools used by emergency medical services are inadequate for recognizing sepsis, say German researchers.
September 26, 2023
Sepsis Bacteria Social
HIV vaccine trial begins enrollment in U.S., South Africa
A clinical trial for a preventive HIV vaccine has begun enrollment in both the U.S. and South Africa.
September 25, 2023
Vial Vaccine Vial Tech Social
Page 1 of 148
Next Page